225 related articles for article (PubMed ID: 25303682)
1. Ezetimibe prevents the formation of oestrogen-induced cholesterol gallstones in mice.
de Bari O; Wang HH; Portincasa P; Paik CN; Liu M; Wang DQ
Eur J Clin Invest; 2014 Dec; 44(12):1159-68. PubMed ID: 25303682
[TBL] [Abstract][Full Text] [Related]
2. Effect of ezetimibe on the prevention and dissolution of cholesterol gallstones.
Wang HH; Portincasa P; Mendez-Sanchez N; Uribe M; Wang DQ
Gastroenterology; 2008 Jun; 134(7):2101-10. PubMed ID: 18442485
[TBL] [Abstract][Full Text] [Related]
3. Ezetimibe prevents cholesterol gallstone formation in mice.
Zúñiga S; Molina H; Azocar L; Amigo L; Nervi F; Pimentel F; Jarufe N; Arrese M; Lammert F; Miquel JF
Liver Int; 2008 Aug; 28(7):935-47. PubMed ID: 18783541
[TBL] [Abstract][Full Text] [Related]
4. Activation of Estrogen Receptor G Protein-Coupled Receptor 30 Enhances Cholesterol Cholelithogenesis in Female Mice.
Wang HH; de Bari O; Arnatt CK; Liu M; Portincasa P; Wang DQ
Hepatology; 2020 Dec; 72(6):2077-2089. PubMed ID: 32112420
[TBL] [Abstract][Full Text] [Related]
5. Activation of liver X receptor sensitizes mice to gallbladder cholesterol crystallization.
Uppal H; Zhai Y; Gangopadhyay A; Khadem S; Ren S; Moser JA; Xie W
Hepatology; 2008 Apr; 47(4):1331-42. PubMed ID: 18318438
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor alpha, but not beta, plays a major role in 17beta-estradiol-induced murine cholesterol gallstones.
Wang HH; Afdhal NH; Wang DQ
Gastroenterology; 2004 Jul; 127(1):239-49. PubMed ID: 15236189
[TBL] [Abstract][Full Text] [Related]
7. A novel GPER antagonist protects against the formation of estrogen-induced cholesterol gallstones in female mice.
DeLeon C; Wang HH; Gunn J; Wilhelm M; Cole A; Arnett S; Wang DQ; Arnatt CK
J Lipid Res; 2020 May; 61(5):767-777. PubMed ID: 32127396
[TBL] [Abstract][Full Text] [Related]
8. Estrogen induces two distinct cholesterol crystallization pathways by activating ERα and GPR30 in female mice.
de Bari O; Wang TY; Liu M; Portincasa P; Wang DQ
J Lipid Res; 2015 Sep; 56(9):1691-700. PubMed ID: 26152119
[TBL] [Abstract][Full Text] [Related]
9. Differences between hepatic and biliary lipid metabolism and secretion in genetically gallstone-susceptible and gallstone-resistant mice.
Xu G; Zhao L; Fuchs M
Chin Med J (Engl); 2002 Sep; 115(9):1292-5. PubMed ID: 12411097
[TBL] [Abstract][Full Text] [Related]
10. Pioglitazone prevents cholesterol gallstone formation through the regulation of cholesterol homeostasis in guinea pigs with a lithogenic diet.
Han T; Lv Y; Wang S; Hu T; Hong H; Fu Z
Lipids Health Dis; 2019 Dec; 18(1):218. PubMed ID: 31829191
[TBL] [Abstract][Full Text] [Related]
11. Prevention of cholesterol gallstones by inhibiting hepatic biosynthesis and intestinal absorption of cholesterol.
Wang HH; Portincasa P; de Bari O; Liu KJ; Garruti G; Neuschwander-Tetri BA; Wang DQ
Eur J Clin Invest; 2013 Apr; 43(4):413-26. PubMed ID: 23419155
[TBL] [Abstract][Full Text] [Related]
12. Inhibiting intestinal NPC1L1 activity prevents diet-induced increase in biliary cholesterol in Golden Syrian hamsters.
Valasek MA; Repa JJ; Quan G; Dietschy JM; Turley SD
Am J Physiol Gastrointest Liver Physiol; 2008 Oct; 295(4):G813-22. PubMed ID: 18718997
[TBL] [Abstract][Full Text] [Related]
13. Effect of Inhibition of Intestinal Cholesterol Absorption on the Prevention of Cholesterol Gallstone Formation.
Portincasa P; Wang DQ
Med Chem; 2017; 13(5):421-429. PubMed ID: 28185534
[TBL] [Abstract][Full Text] [Related]
14. Augmented cholesterol absorption and sarcolemmal sterol enrichment slow small intestinal transit in mice, contributing to cholesterol cholelithogenesis.
Xie M; Kotecha VR; Andrade JD; Fox JG; Carey MC
J Physiol; 2012 Apr; 590(8):1811-24. PubMed ID: 22331417
[TBL] [Abstract][Full Text] [Related]
15. Ezetimibe ameliorates cholecystosteatosis.
Mathur A; Walker JJ; Al-Azzawi HH; Lu D; Swartz-Basile DA; Nakeeb A; Pitt HA
Surgery; 2007 Aug; 142(2):228-33. PubMed ID: 17689690
[TBL] [Abstract][Full Text] [Related]
16. Aging per se is an independent risk factor for cholesterol gallstone formation in gallstone susceptible mice.
Wang DQ
J Lipid Res; 2002 Nov; 43(11):1950-9. PubMed ID: 12401894
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic characterization of lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice. Pathophysiology Of biliary lipid secretion.
Wang DQ; Lammert F; Paigen B; Carey MC
J Lipid Res; 1999 Nov; 40(11):2066-79. PubMed ID: 10553010
[TBL] [Abstract][Full Text] [Related]
18. Deficiency of Niemann-Pick C1 protein protects against diet-induced gallstone formation in mice.
Morales MG; Amigo L; Balboa E; Acuña M; Castro J; Molina H; Miquel JF; Nervi F; Rigotti A; Zanlungo S
Liver Int; 2010 Jul; 30(6):887-97. PubMed ID: 20408952
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of intestinal absorption of cholesterol by ezetimibe or bile acids by SC-435 alters lipoprotein metabolism and extends the lifespan of SR-BI/apoE double knockout mice.
Braun A; Yesilaltay A; Acton S; Broschat KO; Krul ES; Napawan N; Stagliano N; Krieger M
Atherosclerosis; 2008 May; 198(1):77-84. PubMed ID: 18054357
[TBL] [Abstract][Full Text] [Related]
20. Cholesterol cholelithiasis in pregnant women: pathogenesis, prevention and treatment.
de Bari O; Wang TY; Liu M; Paik CN; Portincasa P; Wang DQ
Ann Hepatol; 2014; 13(6):728-45. PubMed ID: 25332259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
